BCBS Rhode Island reported a net gain of $602,000 (0.1% margin) for the year ended Dec. 31, which was attributed to administrative cost reductions and a positive performance for its investment portfolio, according to an April 10 news release.
Monthly payments to providers rose by $16 million in 2023 to $152 million per month, according to the release. Annual claims expenses for hospital-administered drugs, medical and surgical services, imaging and diagnostics grew by $85 million over 2022.
The payer said pharmaceutical claims grew by $75 million, which was led by a 1,300% increase in the commercial market’s use of some GLP-1 drugs. The company also said utilization of high-cost specialty medications for autoimmune diseases grew 20% as approved conditions for treatment expanded.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 17–19 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
